Complix raises EUR 12 million in series B

Complix N.V. (Diepenbeek, Belgium) raised EUR 12 million ($15.7 million) in a series B round co-led by new investors Edmond de Rothschild Investment Partners; Gimv; and Biotech Fund Flanders, which is managed by Gimv. Existing investors LRM N.V.; Omnes Capital; Vesalius Biocapital Partners; Gemma Frisius Fund; TrustCapital; Vinnof; Baekeland Fund; Centre de Recherche Public de la Sante; and company management also participated. EdRIP's Gilles Nobecourt and Gimv's Patrick Van Beneden will join Complix's board. ...